Organizing Body

Sponsored by

The International Society for Preventive Oncology

in official relations with

The World Health Organization
The International Agency for Research on Cancer

cosponsored by

The French National League Against Cancer
Curie Institute (Paris)
Gustave Roussy Institute (Villejuif)
University of Nice Sophia-Antipolis Faculty of Medicine
The Italian National League Against Cancer
National Institute for Research on Cancer (Genoa)
Advanced Biotechnology Center (Genoa)
University of Illinois College of Medicine (Urbana)
University of Massachusetts Medical Center (Worcester)


HO Adami MD
Dept Medical Epidemiology
Karolinska Institute, Stockholm, Sweden
H Bartsch PhD
Div Toxicology & Cancer Risk Factors
German Cancer Research Center, Heidelberg, Germany
P Basset MD PhD
IGBMC, CNRS, University Strasbourg 1
Illkirch Graffens, France
P Beaune
CHU Necker Enfants Malades, Paris, France
MJJ Berns PhD
Dr Daniel Den Hoed Cancer Center
Dept Medical Oncology, Rotterdam, Netherlands
H Bohlen MD
Clinic of Internal Medicine
University of Cologne, Cologne, Germany
FX Bosch
University of Heidelberg, Heidelberg, Germany
DG Bostwick MD
Dept Pathology
Mayo Clinic & Mayo Foundation, Rochester MN
E Bresnick PhD
University of Massachusetts Medical Center
LWK Chung PhD
Molecular Urology & Therapeutics Program
University of Virginia School of Medicine, Charlottesville VA
G de Thé MD
Unit Epidemiology of Viral Oncogenesis
Pasteur Institut, Paris, France
WH Fridman PhD
Immunology Lab
Institut Curie, Paris, France
H Fujiki MD
Saitama Cancer Center Research Institute, Saitama, Japan
AM Gerwirtz MD
Dept Pathology & Laboratory Medicine
University Pennsylvania, Philadelphia PA
JB Gibbs PhD
Merck Sharp & Dohme Ltd, West Point PA
M Gottardis PhD
Dept Endocrine Research
Ligand Pharmaceuticals, San Francisco CA
DA Haber
Molecular Genetics Lab
Massachusetts General Hospital, Cancer Center, Boston MA
A Harstrick MD
Dept Internal Medicine, West German Cancer Center, Essen, Germany
R Hayes
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda MD
WJM Hrushesky MD
New York State Department of Health
Wadsworth Center, Albany NY
B Huber
Pharmacology & Molecular Therapeutics,
Glaxo/Wellcome, Research Triangle Park NC
H Ioachim MD
Dept Pathology
Lenox Hill Hospital, New York NY
Geron Corp, Menlo Pk CA
P Kleihues MD
International Agency for Research on Cancer, Lyon, France
D Li PhD
Dept Clinical Investigation
The University of Texas MD Anderson Cancer Center, Houston TX
L Mao MD
Dept Thoracic Head & Neck Medical Oncology
University Texas MD Anderson Cancer Ctr, Houston TX
F Marincola MD
National Cancer Institute, Surgical Branch, NIH
Clinical Oncology Program, Bethesda MD
T Minamoto
Kanazawa University, Kanazawa, Japan
M Nerenberg
Nanogen, San Diego CA
D Palli MD
Epidemiology Unit, CSPO
Azienda Ospedale Careggi, Florence, Italy
N Restifo MD
Surgery Branch
National Cancer Institute, Bethesda MD
ZA Ronai PhD
Ruttenberg Cancer Center
Mt Sinai Medical Center, New York NY
AR Sarasin PhD
CNRS Cancer Research Institute, Villejuif, France
P Sonneveld MD PhD
Dept Hematology, University Hospital, Rotterdam, Netherlands
M Soulilou
Universite de Rennes I Faculty de Medecine, Rennes, France
H Tahara
Lab of Molecular Carcinogenesis
National Institute of Environmental Health Sciences, Research Triangle Park NC
G Thomas MD
Centre d'Etudes du Polymorphisme Humain, Hopital St Antoine, Paris, France
TD Tlsty PhD
Dept Pathology
University of California, San Francisco CA
JM Trent PhD
Cancer Genetics Lab
National Center for Human Genome Research, Bethesda MD
T Tursz ScD MD
Institut Gustave Roussy, Villejuif, France
H Vainio MD
International Agency for Research on Cancer, Lyon, France
S Waxman MD
Dept Medicine, Div Neoplastic Diseases
Mt Sinai Medical Center, New York NY
IB Weinstein MD
College of Physicians & Surgeons
Columbia University, New York NY
H Yamasaki PhD
Unit Multistage Carcinogenesis
International Agency for Research on Cancer, Lyon, France

Program Committee

JF Bach MD
Nephrology Unit, Necker Hospital
Paris, France
E Bresnick, PhD
Vice Chancellor, Research, University of Massachusetts Medical Ctr
Worcester MA
G de Thé, MD PhD
Director, Epidemiology Oncogenic Viruses, Institut Pasteur
Paris, France
C Dittrich, MD
Head, Boltzmann Inst Applied Cancer Res, Kaiser F Josef Hospital
Vienna Austria
H Fujiki, MD
Saitama Cancer Research Institute
Saitama, Japan
RA Good, MD PhD
Dept Pediatrics, All Children's Hospital University S Florida
St. Petersburg FL
J Horton, MB ChB
Editor, Cancer Control, F. Lee Moffitt Cancer Center
Tampa FL
P Kleihues, MD
Director, International Agency Research on Cancer
Lyon, France
S Kyrtopoulos MD
National Hellenic Research Fndn
Athens, Greece
NP Napalkov, MD
Assistant Director-General, World Health Organization
Geneva Switzerland
HE Nieburgs, MD
Professor of Pathology, University of Massachusetts Medical School
Worcester MA
P Rampal MD
Dean, University of Nice Sophia Antipolis
Faculty of Medicine, Nice France
Z Ronai, PhD
Mount Sinai Medical Center
New York, NY
L Santi, MD
Scientific Director, Istituto Scientifico per lo Studio e la Cura
dei Tumori
VEO Valli, PhD DVM
Dean, College of Veterinary Medicine, University of Illinois
Urbana IL
IB Weinstein, MD PhD
Columbia-Presbyterian Cancer Center
New York NY
CW Wild, PhD
University of Leeds Cancer Research Center
Leeds, England